Trial
NCT04858425
Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Entero Therapeutics
Collaborators
—
Condition
Covid19
Intervention
Niclosamide
Why stopped
The termination of the study was a decision based on topline data analysis (no efficacy as per Day 43) of the study data.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-08